TABLE 2.
Physical characteristics of enrolled study participants by the randomization sequence
| Treatment sequence |
||||||
|---|---|---|---|---|---|---|
| ABC | ACB | BAC | BCA | CAB | CBA | |
| Sex, n (%) | ||||||
| Male | 2 (66.6) | 1 (50) | 1 (33.3) | 2 (40) | 0 (0) | 4 (80) |
| Female | 1 (33.3) | 1 (50) | 2 (66.6) | 3 (60) | 2 (100) | 1 (20) |
| Age (y) | 26.33 ± 1.50 | 31.50 ± 10.61 | 26.00 ± 2.52 | 27.40 ± 3.44 | 25.00 ± 0.00 | 30.20 ± 5.98 |
| BMI (kg/m2) | 24.63 ± 3.62 | 22.65 ± 3.89 | 21.10 ± 0.50 | 24.20 ± 4.15 | 25.20 ± 0.99 | 23.52 ± 1.90 |
| Fasted plasma glucose (mM) | 5.00 ± 0.25 | 4.92 ± 0.40 | 4.53 ± 0.17 | 5.00 ± 0.48 | 4.65 ± 0.21 | 4.56 ± 0.16 |
| Fasted total cholesterol (mM) | 4.48 ± 0.65 | 4.91 ± 0.40 | 4.71 ± 0.43 | 4.76 ± 1.03 | 4.33 ± 1.68 | 4.50 ± 1.41 |
Values are given as mean ± SD unless otherwise specified.